THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICE;BIOVEST INTERNATIONAL, INC.
发明人:
Wyndham H. Wilson,Carlos Santos,Larry W. Kwak,Sattva S. Neelapu
申请号：
US14362093
公开号：
US20140363456A1
申请日:
2012.12.07
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to methods of treating cancer with a cancer vaccine using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a biomarker； methods of prognosticating an outcome of cancer treatment with a cancer vaccine using GM-CSF as a biomarker； methods for qualifying subjects for cancer vaccination using GM-CSF as a biomarker； methods for comparing the efficacy of two or more cancer vaccine treatments based on GM-CSF response； and kits for the effective treatment of cancer.
